🇺🇸 FDA
Pipeline program

LB1908

LB1908-1001

Phase 1 mab active

Quick answer

LB1908 for Gastric Cancer is a Phase 1 program (mab) at Legend Biotech Corp with 1 ClinicalTrials.gov record(s).

Program details

Company
Legend Biotech Corp
Indication
Gastric Cancer
Phase
Phase 1
Modality
mab
Status
active

Clinical trials